Radcliffe Cardiology Announces New Educational Hub, Arrhythmia Academy

Radcliffe Cardiology: An exciting new digital platform – ‘Arrhythmia Academy’ launches today – dedicated to arrhythmia and electrophysiology specialists.

This new scientific content hub is led by Editor-in-Chief Prof Angelo Auricchio, MD, Ph.D., (Lugano, Switzerland) and is supported by a stellar, international editorial board.

In association with leading Cardiovascular content provider Radcliffe Cardiology, Arrhythmia Academy aims to provide high-quality, peer-to-peer content for clinicians interested in cardiac arrhythmias and clinical cardiac care electrophysiology. It will welcome contributions by health care professionals working in this specialty.

Features include:

  • Case Lab: with real-world content, including practical ‘how-to guides’, videos, technical tips and tricks and a host of challenging and unusual case examples designed to enhance study
  • Education: dedicated to key scientific learnings, methods and commentaries
  • Innovations: showcasing new technological developments in AF and EP medicine. Featuring news, conference highlights, late-breaking trials and the latest developments from the industry.
  • Editorial Area: regularly updated with key editorials and opinion pieces on a particular issue, event, or gap in the literature.

VISIT SITE >

All of the content will be created in an accessible and digestible format: short written summaries, presentations, videos, audio podcasts and imagery, aiming to bring clinicians the most relevant and practical information as succinctly and as timely as possible.

If you think you might have something of interest to contribute, you can visit the site now and submit your content.

“As a scientist first, then, as Editor-in-Chief, I am very excited to launch this web-based platform that completes, and significantly expands upon the current editorial offering, with open-access and visual digital content. I am also very grateful to a large number of scientists and key opinion leaders in the field of cardiac arrhythmias, who have accepted to be part of the editorial board and are committed to providing tremendous support to this initiative.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.